American International Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-48,024
| Closed | -$864K | – | 3146 |
|
|
2020
Q2 | $864K | Buy |
48,024
+2,889
| +6% | +$40.2K | ﹤0.01% | 1300 |
|
|
2020
Q1 | $322K | Sell |
45,135
-2,606
| -5% | -$32.5K | ﹤0.01% | 1648 |
|
|
2019
Q4 | $1.14M | Buy |
47,741
+555
| +1% | +$15.3K | ﹤0.01% | 1267 |
|
|
2019
Q3 | $1.27M | Buy |
47,186
+4,755
| +11% | +$133K | 0.01% | 1169 |
|
|
2019
Q2 | $1.15M | Buy |
42,431
+908
| +2% | +$28.5K | ﹤0.01% | 1248 |
|
|
2019
Q1 | $1.44M | Sell |
41,523
-1,344
| -3% | -$38.8K | 0.01% | 1135 |
|
|
2018
Q4 | $837K | Sell |
42,867
-330
| -0.8% | -$6.79K | ﹤0.01% | 1371 |
|
|
2018
Q3 | $1.15M | Buy |
43,197
+777
| +2% | +$25.4K | ﹤0.01% | 1356 |
|
|
2018
Q2 | $1.6M | Buy |
42,420
+6,077
| +17% | +$232K | 0.01% | 1113 |
|
|
2018
Q1 | $1.19M | Sell |
36,343
-1,955
| -5% | -$85.8K | ﹤0.01% | 1174 |
|
|
2017
Q4 | $1.86M | Buy |
38,298
+1,667
| +5% | +$84.3K | 0.01% | 1044 |
|
|
2017
Q3 | $1.98M | Buy |
36,631
+5,813
| +19% | +$341K | 0.01% | 992 |
|
|
2017
Q2 | $1.73M | Buy |
30,818
+1,010
| +3% | +$40.5K | 0.01% | 1019 |
|
|
2017
Q1 | $1.17M | Buy |
29,808
+1,483
| +5% | +$47.2K | ﹤0.01% | 1129 |
|
|
2016
Q4 | $636K | Sell |
28,325
-74
| -0.3% | -$1.45K | ﹤0.01% | 1491 |
|
|
2016
Q3 | $645K | Buy |
28,399
+43
| +0.2% | +$1.01K | ﹤0.01% | 1460 |
|
|
2016
Q2 | $669K | Sell |
28,356
-3,219
| -10% | -$79.5K | ﹤0.01% | 1424 |
|
|
2016
Q1 | $644K | Buy |
31,575
+1,578
| +5% | +$50.1K | ﹤0.01% | 1808 |
|
|
2015
Q4 | $1.54M | Sell |
29,997
-76
| -0.3% | -$3.69K | 0.01% | 1230 |
|
|
2015
Q3 | $1.28M | Buy |
30,073
+32
| +0.1% | +$1.54K | 0.01% | 1305 |
|
|
2015
Q2 | $1.37M | Sell |
30,041
-19,280
| -39% | -$776K | 0.01% | 1362 |
|
|
2015
Q1 | $1.87M | Buy |
49,321
+10,329
| +26% | +$355K | 0.01% | 1207 |
|
|
2014
Q4 | $1.1M | Buy |
38,992
+14,232
| +57% | +$396K | ﹤0.01% | 1492 |
|
|
2014
Q3 | $626K | Buy |
24,760
+633
| +3% | +$16.7K | ﹤0.01% | 1939 |
|
|
2014
Q2 | $704K | Buy |
24,127
+16,701
| +225% | +$404K | ﹤0.01% | 1881 |
|
|
2014
Q1 | $192K | Buy |
7,426
+178
| +2% | +$4.75K | ﹤0.01% | 2884 |
|
|
2013
Q4 | $187K | Buy |
7,248
+755
| +12% | +$18.3K | ﹤0.01% | 2832 |
|
|
2013
Q3 | $174K | Buy |
+6,493
| New | +$155K | ﹤0.01% | 2856 |
|
American International Group's PTLA Position: Q3 2020 in Review
American International Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 48,024 shares — an estimated $864K sold.
American International Group first reported a position in PTLA in Q3 2013 and held it in 28 quarters. The position peaked at $1.98M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- American International Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- American International Group sold 48,024 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $864K.
- American International Group first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 28 quarters.
- American International Group's Portola Pharmaceuticals, Inc. position peaked at $1.98M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on American International Group's 13F filing for Q3 2020, filed 4 Nov 2020.